Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Outcomes of early ileocolectomy after percutaneous drainage for perforated ileocolic Crohn's disease.

Sangster W, Berg AS, Choi CS, Connelly TM, Chesnut CH 3rd, Koltun WA, Stewart DB Sr.

Am J Surg. 2016 Oct;212(4):728-734. doi: 10.1016/j.amjsurg.2016.01.044. Epub 2016 May 12.

PMID:
27262753
2.

Penetrating Cardiac Nail Gun Injury in a Child.

Kulaylat AN, Chesnut CH 3rd, Patel S, Rocourt DV, Clark JB.

Pediatr Emerg Care. 2016 Aug;32(8):536-7. doi: 10.1097/PEC.0000000000000449.

PMID:
27018525
3.

The profile of successful applicants for endocrine surgery fellowships: results of a national survey.

Kulaylat AN, Kenning EM, Chesnut CH 3rd, James BC, Schubart JR, Saunders BD.

Am J Surg. 2014 Oct;208(4):685-9. doi: 10.1016/j.amjsurg.2014.03.013. Epub 2014 Jun 21.

4.

Successful operative rib fixation of traumatic flail chest in a patient with osteogenesis imperfecta.

Kulaylat AN, Chesnut CH 3rd, Santos AP, Armen SB.

Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):518-9. doi: 10.1093/icvts/ivu191. Epub 2014 Jun 4.

PMID:
24899593
5.

Can PET-CT imaging and radiokinetic analyses provide useful clinical information on atypical femoral shaft fracture in osteoporotic patients?

Chesnut CH 4th, Chesnut CH 3rd.

Curr Osteoporos Rep. 2012 Mar;10(1):42-7. doi: 10.1007/s11914-011-0088-6.

PMID:
22286527
6.

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.

Christiansen C, Chesnut CH 3rd, Adachi JD, Brown JP, Fernandes CE, Kung AW, Palacios S, Levine AB, Chines AA, Constantine GD.

BMC Musculoskelet Disord. 2010 Jun 22;11:130. doi: 10.1186/1471-2474-11-130.

7.

Lasofoxifene in postmenopausal women with osteoporosis.

Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R; PEARL Study Investigators.

N Engl J Med. 2010 Feb 25;362(8):686-96. doi: 10.1056/NEJMoa0808692. Erratum in: N Engl J Med. 2011 Jan 20;364(3):290. Kucu kdeveci A [corrected to Kucukdeveci, A].

8.

Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology.

Armbrecht G, Blenk T, Chesnut CH 3rd, Gardner JC, von Ingersleben G, Mahoney P, Felsenberg D.

J Clin Densitom. 2008 Apr-Jun;11(2):221-31. Epub 2007 Dec 26.

PMID:
18158264
9.

Salmon calcitonin: a review of current and future therapeutic indications.

Chesnut CH 3rd, Azria M, Silverman S, Engelhardt M, Olson M, Mindeholm L.

Osteoporos Int. 2008 Apr;19(4):479-91. Epub 2007 Dec 11. Review.

PMID:
18071651
10.

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.

Carpenter PA, Hoffmeister P, Chesnut CH 3rd, Storer B, Charuhas PM, Woolfrey AE, Sanders JE.

Biol Blood Marrow Transplant. 2007 Jun;13(6):683-90. Epub 2007 Apr 6.

11.

Review of treatment modalities for postmenopausal osteoporosis.

Hamdy RC, Chesnut CH 3rd, Gass ML, Holick MF, Leib ES, Lewiecki ME, Maricic M, Watts NB.

South Med J. 2005 Oct;98(10):1000-14; quiz 1015-7, 1048. Review.

PMID:
16295815
12.

Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.

Chesnut CH 3rd, Majumdar S, Newitt DC, Shields A, Van Pelt J, Laschansky E, Azria M, Kriegman A, Olson M, Eriksen EF, Mindeholm L.

J Bone Miner Res. 2005 Sep;20(9):1548-61. Epub 2005 Apr 27.

13.

Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data.

Adachi JD, Rizzoli R, Boonen S, Li Z, Meredith MP, Chesnut CH 3rd.

Aging Clin Exp Res. 2005 Apr;17(2):150-6.

PMID:
15977464
14.

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

Chesnut CH 3rd, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD; Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE).

J Bone Miner Res. 2004 Aug;19(8):1241-9. Epub 2004 Mar 29.

15.

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.

Recker R, Stakkestad JA, Chesnut CH 3rd, Christiansen C, Skag A, Hoiseth A, Ettinger M, Mahoney P, Schimmer RC, Delmas PD.

Bone. 2004 May;34(5):890-9.

PMID:
15121021
16.

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study.

Delmas PD, Recker RR, Chesnut CH 3rd, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C.

Osteoporos Int. 2004 Oct;15(10):792-8. Epub 2004 Apr 8.

PMID:
15071723
17.

Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.

McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH 3rd, Ensrud KE, Burdeska A, Mills T; Oral Ibandronate Study Group.

J Bone Miner Res. 2004 Jan;19(1):11-8.

18.

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.

Recker RR, Weinstein RS, Chesnut CH 3rd, Schimmer RC, Mahoney P, Hughes C, Bonvoisin B, Meunier PJ.

Osteoporos Int. 2004 Mar;15(3):231-7. Epub 2004 Jan 16.

PMID:
14727011
19.

Short-term calcium supplementation has no effect on biochemical markers of bone remodeling in early postmenopausal women.

Ulrich U, Miller PB, Eyre DR, Chesnut CH 3rd, Bodenschatz C, Schlebusch H, Soules MR.

Arch Gynecol Obstet. 2004 Dec;270(4):230-4. Epub 2003 Nov 28.

PMID:
14648073
20.

Bone remodeling and bone mineral density during pregnancy.

Ulrich U, Miller PB, Eyre DR, Chesnut CH 3rd, Schlebusch H, Soules MR.

Arch Gynecol Obstet. 2003 Oct;268(4):309-16. Epub 2003 Jan 8.

PMID:
14504876

Supplemental Content

Loading ...
Support Center